150 related articles for article (PubMed ID: 38164269)
1. Survival effects of postoperative adjuvant TACE in early-HCC patients with microvascular invasion: A multicenter propensity score matching.
Qian J; Shen Y; Cui L; Wu Z; Tu S; Lin W; Tang H; Hu Z; Liu L; Shen W; He Y; He K
J Cancer; 2024; 15(1):68-78. PubMed ID: 38164269
[No Abstract] [Full Text] [Related]
2. Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort.
Luo L; Shan R; Cui L; Wu Z; Qian J; Tu S; Zhang W; Xiong Y; Lin W; Tang H; Zhang Y; Zhu J; Huang Z; Li Z; Mao S; Li H; Hu Z; Peng P; He K; Li Y; Liu L; Shen W; He Y
United European Gastroenterol J; 2023 Mar; 11(2):228-241. PubMed ID: 36905230
[TBL] [Abstract][Full Text] [Related]
3. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
4. Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study.
Wang L; Ke Q; Lin K; Chen J; Wang R; Xiao C; Liu X; Liu J
Cancer Manag Res; 2020; 12():3815-3825. PubMed ID: 32547217
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China.
Wu Z; Cui L; Qian J; Luo L; Tu S; Cheng F; Yuan L; Zhang W; Lin W; Tang H; Li X; Li H; Zhang Y; Zhu J; Li Y; Xiong Y; Hu Z; Peng P; He Y; Liu L; He K; Shen W
BMC Cancer; 2023 Apr; 23(1):325. PubMed ID: 37029339
[TBL] [Abstract][Full Text] [Related]
7. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
[TBL] [Abstract][Full Text] [Related]
8. Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.
Wang H; Du PC; Wu MC; Cong WM
Hepatobiliary Surg Nutr; 2018 Dec; 7(6):418-428. PubMed ID: 30652086
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis.
Wen Y; Lu L; Mei J; Ling Y; Guan R; Lin W; Wei W; Guo R
J Hepatocell Carcinoma; 2024; 11():665-678. PubMed ID: 38596593
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Shen A; Liu M; Zheng D; Chen Q; Wu Z
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
[TBL] [Abstract][Full Text] [Related]
13. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC
HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510
[TBL] [Abstract][Full Text] [Related]
14. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
[TBL] [Abstract][Full Text] [Related]
15. Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study.
Xiang C; Shen X; Zeng X; Zhang Y; Ma Z; Zhang G; Song X; Huang T; Yang J
Int J Surg; 2024 Jan; 110(1):315-323. PubMed ID: 37812183
[TBL] [Abstract][Full Text] [Related]
16. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP
Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149
[TBL] [Abstract][Full Text] [Related]
18. Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis.
Wang L; Chen B; Li Z; Yao X; Liu M; Rong W; Wu F; Lin S; Liu Y; Zheng Y; Li Y; Wang W; Wu J
Onco Targets Ther; 2019; 12():1237-1247. PubMed ID: 30863091
[TBL] [Abstract][Full Text] [Related]
19. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
Liu S; Li H; Guo L; Zhang B; Zhou B; Zhang W; Zhou J; Fan J; Ye Q
Oncologist; 2019 Apr; 24(4):513-520. PubMed ID: 30552155
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
